secwatch.observer — SEC 8-K summary
======================================

Issuer:     NKGen Biotech, Inc. (—)
CIK:        0001845459
Form:       8-K
Filed at:   2024-04-05T23:59:59+00:00
Accession:  0001104659-24-044244
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NKGen Biotech issues $550K in convertible promissory notes and warrants
-----------------------------------------------------------------------

- Issued 12% promissory notes totaling $550K principal ($500K net) to AJB Capital and Sandia Investment Management.
- Notes mature April 1, 2025, convertible into common stock at $2.00 per share.
- Also issued warrants to purchase up to 550,000 shares at $2.00 per share for five years.
- Proceeds provide working capital; notes include original issue discount and default interest provisions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845459/000110465924044244/0001104659-24-044244-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845459/000110465924044244/tm2411210d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-044244

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer